Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Revenue

In the year 2025, Apellis Pharmaceuticals had annual revenue of $1.00B with 28.46% growth. Apellis Pharmaceuticals had revenue of $199.91M in the quarter ending December 31, 2025, a decrease of -5.94%.

• Revenue (ttm): $1.00B
• Revenue Growth: +28.46%
• P/S Ratio: 5.20
• Revenue / Employee: $1,358,298
• Employees: 739
• Market Cap: 5.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.00B	222.41M	28.46%
Dec 31, 2024	781.37M	384.78M	97.02%
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-